Global Artificial Blood Market by Manufacturers, Countries, Type and Application, Forecast to 2023

  • receipt Report ID : 137071
  • calendar_today Published On: Jan, 2019
  • file_copy Pages: 132
  • list Pharmaceuticals and Healthcare

Artificial blood, also called oxygen therapeutics or hemoglobin-based oxygen carriers, offer the promise of new life-saving medical treatments.

Scope of the Report:

This report studies the Artificial Blood market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Artificial Blood market by product type and applications/end industries.

Artificial blood or synthetic blood and blood products are the alternatives to the blood transfusion to replace the blood. It fulfills and replicates the normal functions of the body. Artificial blood is infused in the traumatic injuries and other disease conditions for the transportation of carbon di oxide and oxygen across the body.

The global Artificial Blood market is valued at 2750 million USD in 2017 and is expected to reach 7900 million USD by the end of 2023, growing at a CAGR of 19.3% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Artificial Blood.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Dextro-Sang Corporation

BioPure Corporation

Sangart

Northfield Laboratories

Baxter International

Dentritech

FluorO2 Therapeutics

Nuvox Pharma

Alpha Therapeutic Corporation

HemoBioTech

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Human Blood

Synthetic Blood

Animal Blood

Market Segment by Applications, can be divided into

Hemoglobin-Based Oxygen Carriers (HBOCs)

Perflurocarbon Emulsions (PFCEs)

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Artificial Blood Market Overview

1.1 Product Overview and Scope of Artificial Blood

1.2 Classification of Artificial Blood by Types

1.2.1 Global Artificial Blood Revenue Comparison by Types (2017-2023)

1.2.2 Global Artificial Blood Revenue Market Share by Types in 2017

1.2.3 Human Blood

1.2.4 Synthetic Blood

1.2.5 Animal Blood

1.3 Global Artificial Blood Market by Application

1.3.1 Global Artificial Blood Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Hemoglobin-Based Oxygen Carriers (HBOCs)

1.3.3 Perflurocarbon Emulsions (PFCEs)

1.4 Global Artificial Blood Market by Regions

1.4.1 Global Artificial Blood Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Artificial Blood Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Artificial Blood Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Artificial Blood Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Artificial Blood Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Artificial Blood Status and Prospect (2013-2023)

1.5 Global Market Size of Artificial Blood (2013-2023)

2 Manufacturers Profiles

2.1 Dextro-Sang Corporation

2.1.1 Business Overview

2.1.2 Artificial Blood Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Dextro-Sang Corporation Artificial Blood Revenue, Gross Margin and Market Share (2016-2017)

2.2 BioPure Corporation

2.2.1 Business Overview

2.2.2 Artificial Blood Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 BioPure Corporation Artificial Blood Revenue, Gross Margin and Market Share (2016-2017)

2.3 Sangart

2.3.1 Business Overview

2.3.2 Artificial Blood Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Sangart Artificial Blood Revenue, Gross Margin and Market Share (2016-2017)

2.4 Northfield Laboratories

2.4.1 Business Overview

2.4.2 Artificial Blood Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Northfield Laboratories Artificial Blood Revenue, Gross Margin and Market Share (2016-2017)

2.5 Baxter International

2.5.1 Business Overview

2.5.2 Artificial Blood Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Baxter International Artificial Blood Revenue, Gross Margin and Market Share (2016-2017)

2.6 Dentritech

2.6.1 Business Overview

2.6.2 Artificial Blood Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Dentritech Artificial Blood Revenue, Gross Margin and Market Share (2016-2017)

2.7 FluorO2 Therapeutics

2.7.1 Business Overview

2.7.2 Artificial Blood Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 FluorO2 Therapeutics Artificial Blood Revenue, Gross Margin and Market Share (2016-2017)

2.8 Nuvox Pharma

2.8.1 Business Overview

2.8.2 Artificial Blood Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Nuvox Pharma Artificial Blood Revenue, Gross Margin and Market Share (2016-2017)

2.9 Alpha Therapeutic Corporation

2.9.1 Business Overview

2.9.2 Artificial Blood Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Alpha Therapeutic Corporation Artificial Blood Revenue, Gross Margin and Market Share (2016-2017)

2.10 HemoBioTech

2.10.1 Business Overview

2.10.2 Artificial Blood Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 HemoBioTech Artificial Blood Revenue, Gross Margin and Market Share (2016-2017)

3 Global Artificial Blood Market Competition, by Players

3.1 Global Artificial Blood Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Artificial Blood Players Market Share

3.2.2 Top 10 Artificial Blood Players Market Share

3.3 Market Competition Trend

4 Global Artificial Blood Market Size by Regions

4.1 Global Artificial Blood Revenue and Market Share by Regions

4.2 North America Artificial Blood Revenue and Growth Rate (2013-2018)

4.3 Europe Artificial Blood Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Artificial Blood Revenue and Growth Rate (2013-2018)

4.5 South America Artificial Blood Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Artificial Blood Revenue and Growth Rate (2013-2018)

5 North America Artificial Blood Revenue by Countries

5.1 North America Artificial Blood Revenue by Countries (2013-2018)

5.2 USA Artificial Blood Revenue and Growth Rate (2013-2018)

5.3 Canada Artificial Blood Revenue and Growth Rate (2013-2018)

5.4 Mexico Artificial Blood Revenue and Growth Rate (2013-2018)

6 Europe Artificial Blood Revenue by Countries

6.1 Europe Artificial Blood Revenue by Countries (2013-2018)

6.2 Germany Artificial Blood Revenue and Growth Rate (2013-2018)

6.3 UK Artificial Blood Revenue and Growth Rate (2013-2018)

6.4 France Artificial Blood Revenue and Growth Rate (2013-2018)

6.5 Russia Artificial Blood Revenue and Growth Rate (2013-2018)

6.6 Italy Artificial Blood Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Artificial Blood Revenue by Countries

7.1 Asia-Pacific Artificial Blood Revenue by Countries (2013-2018)

7.2 China Artificial Blood Revenue and Growth Rate (2013-2018)

7.3 Japan Artificial Blood Revenue and Growth Rate (2013-2018)

7.4 Korea Artificial Blood Revenue and Growth Rate (2013-2018)

7.5 India Artificial Blood Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Artificial Blood Revenue and Growth Rate (2013-2018)

8 South America Artificial Blood Revenue by Countries

8.1 South America Artificial Blood Revenue by Countries (2013-2018)

8.2 Brazil Artificial Blood Revenue and Growth Rate (2013-2018)

8.3 Argentina Artificial Blood Revenue and Growth Rate (2013-2018)

8.4 Colombia Artificial Blood Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Artificial Blood by Countries

9.1 Middle East and Africa Artificial Blood Revenue by Countries (2013-2018)

9.2 Saudi Arabia Artificial Blood Revenue and Growth Rate (2013-2018)

9.3 UAE Artificial Blood Revenue and Growth Rate (2013-2018)

9.4 Egypt Artificial Blood Revenue and Growth Rate (2013-2018)

9.5 Nigeria Artificial Blood Revenue and Growth Rate (2013-2018)

9.6 South Africa Artificial Blood Revenue and Growth Rate (2013-2018)

10 Global Artificial Blood Market Segment by Type

10.1 Global Artificial Blood Revenue and Market Share by Type (2013-2018)

10.2 Global Artificial Blood Market Forecast by Type (2018-2023)

10.3 Human Blood Revenue Growth Rate (2013-2023)

10.4 Synthetic Blood Revenue Growth Rate (2013-2023)

10.5 Animal Blood Revenue Growth Rate (2013-2023)

11 Global Artificial Blood Market Segment by Application

11.1 Global Artificial Blood Revenue Market Share by Application (2013-2018)

11.2 Artificial Blood Market Forecast by Application (2018-2023)

11.3 Hemoglobin-Based Oxygen Carriers (HBOCs) Revenue Growth (2013-2018)

11.4 Perflurocarbon Emulsions (PFCEs) Revenue Growth (2013-2018)

12 Global Artificial Blood Market Size Forecast (2018-2023)

12.1 Global Artificial Blood Market Size Forecast (2018-2023)

12.2 Global Artificial Blood Market Forecast by Regions (2018-2023)

12.3 North America Artificial Blood Revenue Market Forecast (2018-2023)

12.4 Europe Artificial Blood Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Artificial Blood Revenue Market Forecast (2018-2023)

12.6 South America Artificial Blood Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Artificial Blood Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Artificial Blood Picture

Table Product Specifications of Artificial Blood

Table Global Artificial Blood and Revenue (Million USD) Market Split by Product Type

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery